Cardinal Health Inc (CAH) : Alerus Financial Na added new position in Cardinal Health Inc during the most recent quarter end. The investment management firm now holds 60,947 shares of Cardinal Health Inc which is valued at $5,095,169 , the company said in a statement filed on Aug 11, 2016 with the SEC.Cardinal Health Inc makes up approximately 0.83% of Alerus Financial Na’s portfolio.
Other Hedge Funds, Including , Tredje Ap-fonden boosted its stake in CAH in the latest quarter, The investment management firm added 891 additional shares and now holds a total of 31,396 shares of Cardinal Health Inc which is valued at $2,624,706. Cardinal Health Inc makes up approx 0.11% of Tredje Ap-fonden’s portfolio.Parnassus Investments Ca boosted its stake in CAH in the latest quarter, The investment management firm added 127,500 additional shares and now holds a total of 357,500 shares of Cardinal Health Inc which is valued at $29,951,350. Cardinal Health Inc makes up approx 0.18% of Parnassus Investments Ca’s portfolio.Aberdeen Asset Management Plcuk reduced its stake in CAH by selling 9,687 shares or 3.82% in the most recent quarter. The Hedge Fund company now holds 244,001 shares of CAH which is valued at $20,652,245. Cardinal Health Inc makes up approx 0.07% of Aberdeen Asset Management Plcuk’s portfolio.Livingston Group Asset Management Co (operating As Southp… reduced its stake in CAH by selling 1,875 shares or 27.95% in the most recent quarter. The Hedge Fund company now holds 4,833 shares of CAH which is valued at $402,782. Cardinal Health Inc makes up approx 0.22% of Livingston Group Asset Management Co (operating As Southp…’s portfolio.
Cardinal Health Inc closed down -0.13 points or -0.16% at $82.02 with 8,99,566 shares getting traded on Tuesday. Post opening the session at $82.39, the shares hit an intraday low of $82 and an intraday high of $82.56 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Investors should note that on Aug 8, 2016, Cardinal Health Inc announced a cash dividend of $0.4489. The company’s management has announced Sep 29, 2016 as the ex-dividend date and fixed the record date on Oct 3, 2016. The payable date has been fixed on Oct 15, 2016.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.